Indirect impacts of COVID-19

Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.

Reducing stroke risk in dementia patients

A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia. The Australian-Swedish study, co-authored by Monash University researchers, focussed...

Bringing pharmacists into the digital future

PSA has unveiled a new digital health report, Connecting the dots: Digitally empowered pharmacists, at the PSA19 conference. The report, funded by the Australian Digital...

Chronic kidney disease: when the filters fail

Chronic kidney disease is a progressive long-term condition characterised by a gradual and usually irreversible decline in kidney function.

Antioxidants and mineral supplements for slowing age-related macular degeneration

Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...

Opioid replacement therapy – supporting treatment

Drug dependence, including opioid dependence, involves a complex interplay of social, psychological and biological factors. Learning objectives After reading this article, pharmacists should be able...